Magnetic resonance imaging of bone metastases in patients with nonseminomatous germ cell tumors

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 3, 2007, Pages 201-206

  Froehner, Michael ^a   Aikele, Peter ^a   Beuthien Baumann, Bettina ^a   Kittner, Thomas ^a   Oehlschlaeger, Sven ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Bone metastases; Bone scan; Germ cell tumor; Magnetic resonance imaging; Residual masses

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT DISEASE;

ADULT; BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; POSITRON-EMISSION TOMOGRAPHY; RETROPERITONEAL NEOPLASMS; TESTICULAR NEOPLASMS;

EID: 34247578204     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.07.017     Document Type: Article

References (13)

1. Clamp A., Danson S., Nguyen H., et al. Assessment of therapeutic response in patients with metastatic bone disease. Lancet Oncol 5 (2004) 607-616
2. Tombal B., Rezazadeh A., Therasse P., et al. Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases. Prostate 65 (2005) 178-187
3. Hamaoka T., Madewell J.E., Podoloff D.A., et al. Bone imaging in metastatic breast cancer. J Clin Oncol 22 (2004) 2942-2953
4. ESMO Guidelines Task Force, Huddart R.A., and Purkalne G. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT). Ann Oncol 16 Suppl 1 (2005) i37-i39
5. Laguna M.P., Pizzocaro G., Klepp O., et al. EAU guidelines on testicular cancer. Eur Urol 40 (2001) 102-110
6. Albers P., Albrecht W., Algaba F., et al. Guidelines on testicular cancer. Eur Urol 48 (2005) 885-894
7. German Testicular Cancer Study Group, Souchon R., Schmoll H.J., and Krege S. Leitlinie zur diagnostik und therapie von hodentumoren auf grundlage evidenzbasierter medizin (EBM). 1st ed. (2002), W. Zuckschwerdt, München (Germany)
8. Schmoll H.J., Souchon R., Krege S., et al. European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15 (2004) 1377-1399
9. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 (1997) 594-603
10. Braga F.J., Arbex M.A., Haddad J., et al. Bone scintigraphy in testicular tumors. Clin Nucl Med 26 (2001) 117-118
11. Bredael J.J., Vugrin D., and Whitmore Jr. W.F. Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 50 (1982) 548-551
12. Bauer H.C.F. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg 87 (2005) 608-617 -B
13. Turner J.W., Hawes D.R., and Williams R.D. Magnetic resonance imaging for detection of prostate cancer metastatic to bone. J Urol 149 (1993) 1482-1484